The Karolinska Kidney Research Center – KaroKidney – is a translational kidney research cluster based in Stockholm, Sweden. KaroKidney promotes programs for synergistic collaborations between basic and clinical researchers that will lead to discoveries and better healthcare strategies aimed at improving outcome for patients with kidney disease.
Read more.
KaroKidney's expanding biobank currently contains more than 600 renal biopsies (>320 native kidney biopsies from adult patients, 110 pediatric patients, 145 living donors and > 50 transplanted patients) and 150 arterial biopsies from patients with ESRD and healthy controls. The tissue is stored in ways that allows analysis of both morphology and RNA/protein expression.
Read more.
Next meeting will be held on April 27, at 3.00 pm.
KaroKidney postdoc position. The Novo Nordisk Fellowship Programme at Karolinska Institutet is currently recruiting three Postdoctoral Research Fellows to support the development of a new generation of exceptional diabetes, endocrinology and metabolism researchers. Deadline is April 8th.
Read more
New publication. A new publication from Stenvinkel
et al. using material from KaroKidney reveals a link between p16 and vascular aging. See more under
Publications
ERA-EDTA 2018. Join KaroKidney to Copenhagen for ERA-EDTA Annual Congress May 24-27. Read more
here
INTRICARE. Peter Stenvinkel from KaroKidney is part of the INTRICARE network, a EU financed research network within Horizon 2020. Read more
here
(article in Swedish) and
here (article in English).
KaroKidney is a collaboration between researchers from Karolinska Institutet, Karolinska University Hospital, SciLifeLab and Karolinska Institutet/AstraZeneca Integrated Cardio Metabolic Centre (ICMC) in Stockholm, Sweden. For more information, visit each institutions website.
Read more
